VERRICA PHARMACEUTICALS INC.

Transcripts Verrica Pharmaceuticals Inc.

Equities

VRCA

US92511W1080

Market Closed - Nasdaq Other stock markets 01:30:00 10/05/2024 am IST			5-day change	1st Jan Change
7.84 ^USD	+3.02%		+15.98%	+7.10%

26/03	Verrica Pharmaceuticals' Ycanth Gets New Chemical Entity Status, Orange Book Listing	MT
26/03	Verrica Pharmaceuticals Announces that YCANTH? Receives New Chemical Entity Status and Orange Book Listing from the FDA	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Verrica Pharmaceuticals Inc., Q4 2023 Earnings Call, Feb 29, 2024	29/02
Transcript : Verrica Pharmaceuticals Inc., Q3 2023 Earnings Call, Nov 09, 2023	09/11
Transcript : Verrica Pharmaceuticals Inc. - Special Call	11/23/11
Transcript : Verrica Pharmaceuticals Inc. - Special Call	24/23/24
Transcript : Verrica Pharmaceuticals Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-02-2021 11:50 AM	02/21/02
Transcript : Verrica Pharmaceuticals Inc. - Special Call	14/20/14
Transcript : Verrica Pharmaceuticals Inc. Presents at Barclays Global Healthcare Conference, Mar-11-2020 04:20 PM	12/20/12
Transcript : Verrica Pharmaceuticals Inc. - Special Call	27/19/27
Transcript : Verrica Pharmaceuticals Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-14-2019 02:35 PM	15/19/15
Transcript : Verrica Pharmaceuticals Inc. - Special Call	03/19/03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW